Cargando…
APOBEC Reporter Systems for Evaluating diNucleotide Editing Levels
Precision genome editing has become a reality with the discovery of base editors. Cytosine base editor (CBE) technologies are improving rapidly but are mostly optimized for TC dinucleotide targets. Here, we report the development and implementation of APOBEC Reporter Systems for Evaluating diNucleot...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Mary Ann Liebert, Inc., publishers
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10611974/ https://www.ncbi.nlm.nih.gov/pubmed/37672599 http://dx.doi.org/10.1089/crispr.2023.0027 |
_version_ | 1785128598506569728 |
---|---|
author | Rieffer, Amanda E. Chen, Yanjun Salamango, Daniel J. Moraes, Sofia N. Harris, Reuben S. |
author_facet | Rieffer, Amanda E. Chen, Yanjun Salamango, Daniel J. Moraes, Sofia N. Harris, Reuben S. |
author_sort | Rieffer, Amanda E. |
collection | PubMed |
description | Precision genome editing has become a reality with the discovery of base editors. Cytosine base editor (CBE) technologies are improving rapidly but are mostly optimized for TC dinucleotide targets. Here, we report the development and implementation of APOBEC Reporter Systems for Evaluating diNucleotide Editing Levels (ARSENEL) in living cells. The ARSENEL panel is comprised of four constructs that quantitatively report editing of each of the four dinucleotide motifs (AC/CC/GC/TC) through real-time accumulation of eGFP fluorescence. Editing rates of APOBEC3Bctd and AIDΔC CBEs reflect established mechanistic preferences with intrinsic biases to TC and GC, respectively. Twelve different (new and established) base editors are tested here using this system with a full-length APOBEC3B CBE showing the greatest on-target TC specificity and an APOBEC3A construct showing the highest editing efficiency. In addition, ARSENEL enables real-time assessment of natural and synthetic APOBEC inhibitors with the most potent to-date being the large subunit of the Epstein–Barr virus ribonucleotide reductase. These reporters have the potential to play important roles in research and development as precision genome engineering technologies progress toward achieving maximal specificity and efficiency. |
format | Online Article Text |
id | pubmed-10611974 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Mary Ann Liebert, Inc., publishers |
record_format | MEDLINE/PubMed |
spelling | pubmed-106119742023-10-29 APOBEC Reporter Systems for Evaluating diNucleotide Editing Levels Rieffer, Amanda E. Chen, Yanjun Salamango, Daniel J. Moraes, Sofia N. Harris, Reuben S. CRISPR J Research Articles Precision genome editing has become a reality with the discovery of base editors. Cytosine base editor (CBE) technologies are improving rapidly but are mostly optimized for TC dinucleotide targets. Here, we report the development and implementation of APOBEC Reporter Systems for Evaluating diNucleotide Editing Levels (ARSENEL) in living cells. The ARSENEL panel is comprised of four constructs that quantitatively report editing of each of the four dinucleotide motifs (AC/CC/GC/TC) through real-time accumulation of eGFP fluorescence. Editing rates of APOBEC3Bctd and AIDΔC CBEs reflect established mechanistic preferences with intrinsic biases to TC and GC, respectively. Twelve different (new and established) base editors are tested here using this system with a full-length APOBEC3B CBE showing the greatest on-target TC specificity and an APOBEC3A construct showing the highest editing efficiency. In addition, ARSENEL enables real-time assessment of natural and synthetic APOBEC inhibitors with the most potent to-date being the large subunit of the Epstein–Barr virus ribonucleotide reductase. These reporters have the potential to play important roles in research and development as precision genome engineering technologies progress toward achieving maximal specificity and efficiency. Mary Ann Liebert, Inc., publishers 2023-10-01 2023-10-10 /pmc/articles/PMC10611974/ /pubmed/37672599 http://dx.doi.org/10.1089/crispr.2023.0027 Text en © Amanda E. Rieffer et al. 2023; Published by Mary Ann Liebert, Inc. https://creativecommons.org/licenses/by/4.0/This Open Access article is distributed under the terms of the Creative Commons License [CC-BY] (http://creativecommons.org/licenses/by/4.0 (https://creativecommons.org/licenses/by/4.0/) ), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Research Articles Rieffer, Amanda E. Chen, Yanjun Salamango, Daniel J. Moraes, Sofia N. Harris, Reuben S. APOBEC Reporter Systems for Evaluating diNucleotide Editing Levels |
title | APOBEC Reporter Systems for Evaluating diNucleotide Editing Levels |
title_full | APOBEC Reporter Systems for Evaluating diNucleotide Editing Levels |
title_fullStr | APOBEC Reporter Systems for Evaluating diNucleotide Editing Levels |
title_full_unstemmed | APOBEC Reporter Systems for Evaluating diNucleotide Editing Levels |
title_short | APOBEC Reporter Systems for Evaluating diNucleotide Editing Levels |
title_sort | apobec reporter systems for evaluating dinucleotide editing levels |
topic | Research Articles |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10611974/ https://www.ncbi.nlm.nih.gov/pubmed/37672599 http://dx.doi.org/10.1089/crispr.2023.0027 |
work_keys_str_mv | AT riefferamandae apobecreportersystemsforevaluatingdinucleotideeditinglevels AT chenyanjun apobecreportersystemsforevaluatingdinucleotideeditinglevels AT salamangodanielj apobecreportersystemsforevaluatingdinucleotideeditinglevels AT moraessofian apobecreportersystemsforevaluatingdinucleotideeditinglevels AT harrisreubens apobecreportersystemsforevaluatingdinucleotideeditinglevels |